• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Nodal disease predicts recurrence whereas other traditional factors affect survival in a cohort of South African patients with differentiated thyroid carcinoma.在一组南非分化型甲状腺癌患者中,淋巴结疾病预示复发,而其他传统因素影响生存。
Cancers Head Neck. 2018 Nov 19;3:10. doi: 10.1186/s41199-018-0037-5. eCollection 2018.
2
Pattern of regional metastases and prognostic factors in differentiated thyroid carcinoma.分化型甲状腺癌的区域性转移模式和预后因素。
Acta Otorhinolaryngol Ital. 2009 Dec;29(6):312-6.
3
The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma.手术、放射性碘及外照射放疗对分化型甲状腺癌患者临床结局的影响。
Cancer. 1998 Jan 15;82(2):375-88.
4
Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients.乳头状和滤泡状甲状腺癌的病理肿瘤-淋巴结-转移(pTNM)分期:700例患者的回顾性分析
J Clin Endocrinol Metab. 1997 Nov;82(11):3553-62. doi: 10.1210/jcem.82.11.4373.
5
Impact of nodal metastases on prognosis in patients with well-differentiated thyroid cancer.淋巴结转移对高分化甲状腺癌患者预后的影响。
Arch Otolaryngol Head Neck Surg. 2002 Jul;128(7):825-8. doi: 10.1001/archotol.128.7.825.
6
[Therapy concept in differentiated thyroid gland carcinoma--results of 25 years with 257 patients].[分化型甲状腺癌的治疗理念——257例患者25年的治疗结果]
Praxis (Bern 1994). 2000 Nov 2;89(44):1779-97.
7
Predictive factors and clinicopathological characteristics of outcome in poorly differentiated thyroid carcinoma: a single-institution study.低分化甲状腺癌预后的预测因素及临床病理特征:一项单机构研究
Front Oncol. 2023 Jul 7;13:1102936. doi: 10.3389/fonc.2023.1102936. eCollection 2023.
8
Management and outcome of recurrent well-differentiated thyroid carcinoma.复发性高分化甲状腺癌的管理与预后
Arch Otolaryngol Head Neck Surg. 2004 Jul;130(7):819-24. doi: 10.1001/archotol.130.7.819.
9
Prognostic Implications of Lymph Node Yield in Central and Lateral Neck Dissections for Well-Differentiated Papillary Thyroid Carcinoma.中央区和侧颈部淋巴结清扫术对分化型甲状腺乳头状癌淋巴结转移的预后意义。
Thyroid. 2016 Mar;26(3):434-40. doi: 10.1089/thy.2015.0318. Epub 2016 Feb 18.
10
Oncological outcomes in differentiated thyroid cancer in South East Scotland.苏格兰东南部分化型甲状腺癌的肿瘤学结局。
Surgeon. 2021 Dec;19(6):e372-e378. doi: 10.1016/j.surge.2020.11.003. Epub 2020 Dec 25.

引用本文的文献

1
CD44 Variant Expression in Follicular Cell-Derived Thyroid Cancers: Implications for Overcoming Multidrug Resistance.CD44变异体在滤泡细胞源性甲状腺癌中的表达:对克服多药耐药性的意义
Molecules. 2025 Apr 24;30(9):1899. doi: 10.3390/molecules30091899.
2
The clinicopathological landscape of thyroid cancer in South Africa-A multi-institutional review.南非甲状腺癌的临床病理概况——一项多机构综述
World J Surg. 2024 Dec;48(12):2863-2870. doi: 10.1002/wjs.12353. Epub 2024 Sep 22.
3
Predictive Value of Clinical and Pathological Characteristics for Metastatic Radioactive Iodine-Refractory Differentiated Thyroid Carcinoma: A 16-year Retrospective Study.临床和病理特征对转移性放射性碘难治性分化型甲状腺癌的预测价值:一项 16 年回顾性研究。
Front Endocrinol (Lausanne). 2022 Jun 28;13:930180. doi: 10.3389/fendo.2022.930180. eCollection 2022.
4
Disease-free Survival of Patients with Differentiated Thyroid Cancer: A Study from a Tertiary Center in Oman.分化型甲状腺癌患者的无病生存期:阿曼一家三级中心的研究
Oman Med J. 2021 Mar 31;36(2):e246. doi: 10.5001/omj.2021.54. eCollection 2021 Mar.

本文引用的文献

1
An International Multi-Institutional Validation of Age 55 Years as a Cutoff for Risk Stratification in the AJCC/UICC Staging System for Well-Differentiated Thyroid Cancer.一项关于将55岁作为AJCC/UICC高分化甲状腺癌分期系统中风险分层临界值的国际多机构验证研究。
Thyroid. 2016 Mar;26(3):373-80. doi: 10.1089/thy.2015.0315. Epub 2016 Feb 25.
2
Presence and Number of Lymph Node Metastases Are Associated With Compromised Survival for Patients Younger Than Age 45 Years With Papillary Thyroid Cancer.对于年龄小于 45 岁的甲状腺乳头状癌患者,淋巴结转移的存在和数量与生存受损有关。
J Clin Oncol. 2015 Jul 20;33(21):2370-5. doi: 10.1200/JCO.2014.59.8391. Epub 2015 Jun 15.
3
Difference between papillary and follicular thyroid carcinoma outcomes: an experience from Egyptian institution.甲状腺乳头状癌和滤泡状癌预后的差异:来自埃及机构的经验。
Cancer Biol Med. 2015 Mar;12(1):53-9. doi: 10.7497/j.issn.2095-3941.2015.0005.
4
Prognostic indicators in well-differentiated thyroid carcinoma when controlling for stage and treatment.在控制分期和治疗因素时,高分化甲状腺癌的预后指标
Laryngoscope. 2015 Apr;125(4):1021-7. doi: 10.1002/lary.25017. Epub 2015 Jan 13.
5
Prognostic factors of survival and recurrence pattern in differentiated thyroid cancer: a retrospective study from Western Turkey.分化型甲状腺癌的生存预后因素及复发模式:来自土耳其西部的一项回顾性研究
Endocr Regul. 2014 Oct;48(4):173-81. doi: 10.4149/endo_2014_04_173.
6
Cervical lymph node metastasis in differentiated thyroid carcinoma: does it have an impact on disease-related morbid events?分化型甲状腺癌的颈部淋巴结转移:它对疾病相关的不良事件有影响吗?
Nucl Med Commun. 2015 Feb;36(2):120-4. doi: 10.1097/MNM.0000000000000234.
7
Guidelines for the management of thyroid cancer.甲状腺癌管理指南。
Clin Endocrinol (Oxf). 2014 Jul;81 Suppl 1:1-122. doi: 10.1111/cen.12515.
8
The impact of lymph node involvement on survival in patients with papillary and follicular thyroid carcinoma.淋巴结受累对乳头状和滤泡状甲状腺癌患者生存的影响。
Surgery. 2008 Dec;144(6):1070-7; discussion 1077-8. doi: 10.1016/j.surg.2008.08.034.
9
Risk factors for thyroid cancer: an epidemiological review focused on nutritional factors.甲状腺癌的危险因素:一项聚焦于营养因素的流行病学综述
Cancer Causes Control. 2009 Feb;20(1):75-86. doi: 10.1007/s10552-008-9219-5. Epub 2008 Sep 3.
10
Prognostic factors and the effect of treatment with radioactive iodine and external beam radiation on patients with differentiated thyroid cancer seen at a single institution over 40 years.40年来在单一机构就诊的分化型甲状腺癌患者的预后因素以及放射性碘和外照射治疗的效果。
Clin Endocrinol (Oxf). 2005 Oct;63(4):418-27. doi: 10.1111/j.1365-2265.2005.02358.x.

在一组南非分化型甲状腺癌患者中,淋巴结疾病预示复发,而其他传统因素影响生存。

Nodal disease predicts recurrence whereas other traditional factors affect survival in a cohort of South African patients with differentiated thyroid carcinoma.

作者信息

Robertson B, Parker M, Shepherd L, Panieri E, Cairncross L, Malherbe F, Ross I L, Omar F, Hunter A

机构信息

Department of Radiation Oncology, Cape Town, South Africa.

2Groote Schuur Hospital, Cape Town, South Africa.

出版信息

Cancers Head Neck. 2018 Nov 19;3:10. doi: 10.1186/s41199-018-0037-5. eCollection 2018.

DOI:10.1186/s41199-018-0037-5
PMID:31093363
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6460678/
Abstract

BACKGROUND AND AIM

Information on patients with differentiated thyroid carcinoma in South Africa is limited. The objective of this study was to review demographics and tumour characteristics in a cohort of patients with differentiated thyroid carcinoma, presenting to Groote Schuur Hospital and evaluate risk factors for recurrence and survival.

PATIENTS AND METHODOLOGY

Retrospective demographic and clinical data were collected on all patients referred between January 2003 and December 2013. Prognostic factors for recurrence free survival and cancer specific survival were assessed using univariate and multivariate analyses.

RESULTS

The total number of patients was 231.The median age at presentation was 44 years and 82% were female patients. The pathological sub-types were papillary (60.6%), follicular (38.9%) and poorly differentiated (0.5%). Total thyroidectomy was performed in 191 patients and 30 patients required neck dissections. A total of 171 (74%) patients received Iodine. The recurrence free and cause specific survival rates at 10 years were 83 and 91%, respectively. Nodal disease at presentation was the only significant risk factor for recurrence ( <  0.001) on multivariate analysis. Significant risk factors for cause specific mortality were age ≥ 45 years ( = 0.006), follicular pathology ( = 0.004), extra-thyroid extension ( = 0.013) and residual tumour ( = 0.004).

CONCLUSIONS

Consistent with international trends, patients with differentiated thyroid carcinoma treated at Groote Schuur Hospital had a favourable prognosis. The known risk factors associated with recurrence and survival in this South African cohort were consistent with those reported in developed countries.

摘要

背景与目的

南非关于分化型甲状腺癌患者的信息有限。本研究的目的是回顾就诊于格罗特·舒尔医院的分化型甲状腺癌患者队列的人口统计学和肿瘤特征,并评估复发和生存的危险因素。

患者与方法

收集了2003年1月至2013年12月期间所有转诊患者的回顾性人口统计学和临床数据。使用单因素和多因素分析评估无复发生存和癌症特异性生存的预后因素。

结果

患者总数为231例。就诊时的中位年龄为44岁,女性患者占82%。病理亚型为乳头状癌(60.6%)、滤泡状癌(38.9%)和低分化癌(0.5%)。191例患者接受了全甲状腺切除术,30例患者需要行颈部淋巴结清扫术。共有171例(74%)患者接受了碘治疗。10年时的无复发生存率和病因特异性生存率分别为83%和91%。多因素分析显示,就诊时的淋巴结疾病是复发的唯一显著危险因素(<0.001)。病因特异性死亡的显著危险因素为年龄≥45岁(=0.006)、滤泡状病理(=0.004)、甲状腺外侵犯(=0.013)和残留肿瘤(=0.004)。

结论

与国际趋势一致,在格罗特·舒尔医院接受治疗的分化型甲状腺癌患者预后良好。该南非队列中与复发和生存相关的已知危险因素与发达国家报道的一致。